Since 2018, there has been a dramatic upsurge in publications relating to the use of vitamin C in critically ill patients, particularly those suffering from sepsis \[[@CR1]\]. This has primarily been in response to the well-publicized before-and-after study of Marik et al. \[[@CR2]\], which indicated that intravenous administration of 6 g/day vitamin C (in combination with thiamine and hydrocortisone) could improve the outcomes of patients with sepsis, including decreasing mortality. Over the past year, seven meta-analyses assessing the effects of vitamin C administration in critically ill patients have been published, with four appearing in the past 4 months alone (see Table [1](#Tab1){ref-type="table"} summary).Table 1A summary of recent meta-analysis of vitamin C administration in critical care patientsPublication detailsTitleSelection criteria (PICO)Included studiesSubgroup analysisFindingsPutzu et al. \[[@CR3]\]Crit Care MedThe effect of vitamin C on clinical outcome in critically ill patients: A systematic review with meta-analysis of randomised controlled trialsP---adult critically ill patientsI---vitC (any regimen)C---placebo or no therapyO---mortality, acute kidney injury, supraventricular arrhythmia, ventricular arrhythmia, stroke, ICU LOS, hospital LOS44 RCTs:16 in ICU setting (*n* = 2857)28 in cardiac surgery (*n* = 3598)Mixed ICU vs burns vs sepsis/septic shock vs acute pancreatitisVitC alone vs enteral vitC vs IV vitC vs IV vitC \> 5 gICU patients:X mortalityX acute kidney injuryX ICU or hospital LOSCardiac surgery:↓ postoperative atrial fibrillation↓ ICU and hospital LOSWang et al. \[[@CR4]\]Ann Intensive CareEffects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysisP---critically ill patientsI---IV vitC (including co-administration of antioxidants)C---placebo or no interventionO---mortality, resuscitation fluid requirement, urine output, acute kidney injury, vasopressor requirement, duration of mechanical ventilation, ICU and/or hospital LOS12 RCT, quasi-RCT, observational (*n* = 1210)Low dose vs medium dose vs high doseBurn vs sepsis vs others↓ mortality (doses of 3--10 g/day)X morality (\< 3 g/day or ≥ 10 g/day)↓ duration of vasopressor support↓ duration of mechanical ventilationX acute kidney injuryX ICU or hospital LOSX fluid requirementX urine outputHemila and Chalker \[[@CR5]\]Vitamin C can shorten the length of stay in the ICU: A meta-analysisP---ICU patientsI---vitCC---placebo or noneO---ICU LOS, duration of mechanical ventilation18 controlled trials (*n* = 2004)including 13 cardiac surgeryIV vs oral1--2 days ICU vs 3--5 days ICU\> 24 h ventilation vs \< 24 h ventilation↓ ICU LOS↓ duration of mechanical ventilationLanglois et al. \[[@CR6]\]JPENVitamin C supplementation in the critically ill: A systematic review and meta-analysisP---ICU patientsI---vitC (enteral or parenteral)C---placebo or noneO---mortality, incident infections, ICU LOS, hospital LOS, duration of mechanical ventilation11 RCTs9 RCTs with mortality (*n* = 1322)Low dose vs high doseCombined therapy vs monotherapyOral/enteral vs parenteralNon-septic vs septicHigher-quality trials vs low-quality trialsX mortality↓ (trend) mortality (IV high dose vitC monotherapy)X infectionsX ICU or hospital LOSX duration of mechanical ventilationZhang and Jativa \[[@CR7]\]SAGE Open MedVitamin C supplementation in the critically ill: A systematic review and meta-analysisP---critically ill adult patientsI---IV vitCC---placebo or no interventionO---mortality, duration of mechanical ventilation, duration of vasopressor support, fluid requirements, urine output4 RCTs and 1 retrospective (*n* = 142)X mortality↓ need for vasopressor support↓ duration of mechanical ventilation↓ (trend) fluid requirements↑ (trend) urine outputLiCrit Care \[[@CR1]\]Evidence is stronger than you think: a meta-analysis of vitamin C use in patients with sepsisP---patients with sepsisI---IV vitCC---placebo or noneO---mortality, ICU LOS, vasopressor duration2 RCTs and 1 before-after↓ mortalityX ICU LOS↓ vasopressor durationLin et al. \[[@CR8]\]Open J Intern MedAdjuvant administration of vitamin C improves mortality of patients with sepsis and septic shock: A systems review and meta-analysisP---patients with septic shock and severe sepsisI---vitCC---placeboO---mortality4 RCTs and 2 retrospective studies (*n* = 109)RCT vs retrospectiveHigh dose vs low doseX mortality↓ mortality (doses of \> 50 mg/kg/day)X ICU LOS*ICU* intensive care unit, *IV* intravenous, *LOS* length of stay, *PICO* patients, intervention, comparator, outcome, *RCT* randomized controlled trial, *vitC* vitamin C

The most recently published and largest meta-analysis included 44 randomized controlled trials (16 intensive care and 28 cardiac surgery) \[[@CR9]\]. Although meta-analyses that include a larger number of studies have increased power, they run the risk of comparing disparate studies. This is particularly the case with vitamin C studies whereby the dose (milligrams vs grams), rout of administration (oral vs intravenous), duration (hours vs days), and disease (e.g., sepsis vs cardiac surgery) can have a large impact on outcomes \[[@CR10], [@CR11]\]. Therefore, appropriate subgroup analyses should be carried out, although this is currently challenging due to the low number of comparable studies.

All but one of the current meta-analyses have focused on mortality as a primary outcome, despite many of the included trials having relatively low numbers of patients. In most cases, no effect of intervention was observed on mortality, except in specific subgroup analyses (e.g., sepsis and higher dose intravenous vitamin C). However, there have been few of these studies published to date, and even fewer of high methodological quality \[6\]. Other commonly assessed outcomes included ICU and hospital length of stay, duration of vasopressor support and mechanical ventilation, and acute kidney injury. Some of the meta-analyses showed decreases in several of these secondary outcomes, while others showed no effect, depending on the selection criteria used for study inclusion (Table [1](#Tab1){ref-type="table"}).

There are currently over a dozen randomized controlled trials registered on [clinicaltrials.gov](http://clinicaltrials.gov) that are assessing the effects of vitamin C administration in critically ill patients, particularly those with sepsis. One would hope that in the short term, no more meta-analyses appear every time another small study is published, but instead wait until some of the larger trials (such as VICTAS and LOVIT) have been completed. Otherwise, there may end up with more meta-analyses than published trials.

This comment refers to the article available at 10.1186/s13054-018-2191-x.
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